Stock Details
GSK is GSK plc's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 43.66$. Average daily volumn in 3 months 5.67M. Market cap 110.87B



Stock symbol : GSK. Exchange : NYSE. Currency : USD
Lastest price : 43.44$. Total volume : 412.84k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

GSK plc (GSK)
Last Price
43.44$
Change
0.33
Volume
412.84k

Previous Close43.11
Open43.31
Day Range43.22-43.46
Bid43.27 x 800
Ask43.28 x 1.1k
Volume412.84k
Average Volume5.67M
Market Cap110.87B
Beta0.25
52 Week Range37.80-46.97
Trailing P/E17.81
Foward P/E12.41
Dividend (Yield %)4.61%
Ex-Dividend Date2022-05-19



Financial Details


According to GSK plc's financial reports the company's revenue in 2021 were 34.11B an decrease(0%) over the years 2020 revenue that were of 34.1B. In 2021 the company's total earnings were 4.38B while total earnings in 2020 were 5.75B(-20%).


Loading ...



Organization

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory... , HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Market Cap:
110.87B
Revenue:
34.11B
Total Assets:
79.1B
Total Cash:
4.27B


News about "GSK plc"

gsk-plc-gsk-and-the-battle-of-fundamentals-vs-technicals-image

GSK plc (GSK) and the Battle of Fundamentals vs. Technicals

Source from : newsheater - 11 hours ago

GSK plc (NYSE:GSK) went down by -0.44% from its latest closing price compared to the recent 1-year high of $46.97. The company’s stock price has collected -0.55% of loss in the last five trading ...See details»


gsk-plc-longsk-insider-emma-walmsley-acquires-7-shares-image

GSK plc (LON:GSK) Insider Emma Walmsley Acquires 7 Shares

Source from : Defense World - 15 hours ago

GSK plc (LON:GSK – Get Rating) insider Emma Walmsley bought 7 shares of the business’s stock in a transaction that occurred on Monday, July 4th. The shares were bought at an average cost of GBX 1,799 ...See details»


right-now-may-be-the-best-buy-in-window-for-gsk-plc-gsk-image

Right Now May Be the Best Buy-In Window for GSK plc (GSK)

Source from : investchronicle - 1 days ago

GSK plc (GSK) is priced at $43.11 after the most recent trading session. At the very opening of the session, the stock price was $43.17 and reached a high price of $43.325, prior to closing the ...See details»


Ipswich Investment Management Co. Inc. Has $443,000 Stock Position in GSK plc (NYSE:GSK)

Source from : Defense World - 12 hours ago

Ipswich Investment Management Co. Inc. lowered its position in shares of GSK plc (NYSE:GSK – Get Rating) by 9.8% in the first quarter, HoldingsChannel reports. The firm owned 10,165 shares of the ...See details»


gsk-investor-support-for-spin-off-vindicates-rejection-of-unilever-bid-says-chief-image

GSK investor support for spin-off vindicates rejection of Unilever bid, says chief

Source from : The Financial Times - 1 days ago

GlaxoSmithKline’s chief executive said a shareholder vote in favour of spinning off its consumer healthcare business vindicated the UK drugmaker’s decision to turn down a £50bn takeover offer from ...See details»


at-4312-gsk-plc-gsk-is-worth-your-consideration-image

At $43.12, GSK plc (GSK) Is Worth Your Consideration

Source from : stocksregister - 7 days ago

GSK plc (NYSE:GSK) at last check was buoying at $43.12 on Thursday, June 30, with a fall of -1.50% from its closing price on previous day. Taking a look at stock we notice that its last check on ...See details»


GSK plc (GSK): Does this stock hold the most enticing factor today?

Source from : investchronicle - 8 days ago

GSK plc (GSK) is priced at $43.35 after the most recent trading session. At the very opening of the session, the stock price was $43.59 and reached a high price of $43.75, prior to closing the session ...See details»


Investors Back GSK’s Demerger Plan

Source from : KamCity - 8 hours ago

The demerger is a key plank of GSK’s turnaround strategy to focus on its core vaccines and pharmaceuticals businesses. Haleon, which owns brands such as Sensodyne, Panadol, Advil, and Centrum, made a ...See details»


Sareum Holdings Says GSK Completes Acquisition of Sierra Oncology

Source from : MarketWatch - 3 days ago

By Michael Susin Sareum Holdings PLC said on Monday that GSK PLC has completes the acquisition of Sierra Oncology for US$1.9 billion in cash and ...See details»


gsks-consumer-health-spinoff-haleon-preps-launch-with-12b-in-debt-image

GSK's con­sumer health spin­off Ha­le­on preps launch with $12B+ in debt

Source from : ENDPOINTS NEWS - 1 days ago

GSK’s consumer health spinoff Haleon will make its big debut in just over a week — but with some serious debt in tow, according to the company. When it lists on the London Stock Exchange on July 18, ...See details»


investors-to-tap-gsks-research-site-for-new-billion-dollar-life-sciences-campus-report-image

In­vestors to tap GSK's re­search site for new bil­lion-dol­lar life sci­ences cam­pus — re­port

Source from : ENDPOINTS NEWS - 2 days ago

Two investors, armed with substantial financial backing, are taking advantage of 33 acres of land at a Big Pharma R&D hub to build a new life sciences campus. A report in The Times and retweeted by ...See details»


atticus-wealth-management-llc-purchases-500-shares-of-gsk-plc-nysegsk-image

Atticus Wealth Management LLC Purchases 500 Shares of GSK plc (NYSE:GSK)

Source from : ETF Daily News - 10 days ago

Atticus Wealth Management LLC raised its position in shares of GSK plc (NYSE:GSK – Get Rating) by 69.8% in the first quarter, according to the company in its most recent filing with the SEC. The ...See details»


gsk-shares-encouraging-data-from-chronic-hepatitis-b-candidate-image

GSK Shares Encouraging Data From Chronic Hepatitis B Candidate

Source from : YAHOO!Finance - 10 days ago

GSK plc (NYSE: GSK) announced promising interim results from the B-Clear phase 2b trial of bepirovirsen in people with chronic hepatitis B (CHB). The data showed that bepirovirsen reduced hepatitis B ...See details»


Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial

Source from : Nasdaq - 13 days ago

Drug majors Sanofi (SNYNF, SNY) and GSK plc (GSK.L) announced Friday positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta (B.1.351) vaccine candidate. Sanofi-GSK ...See details»